UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055371
Receipt number R000063282
Scientific Title Study on healing effect of the fluctuation illumination using pulse wave
Date of disclosure of the study information 2024/09/17
Last modified on 2025/03/01 11:47:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on healing effect of the fluctuation illumination using pulse wave

Acronym

Study on healing effect of the fluctuation illumination using pulse wave

Scientific Title

Study on healing effect of the fluctuation illumination using pulse wave

Scientific Title:Acronym

Study on healing effect of the fluctuation illumination using pulse wave

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to develop the healing LED light by using the user's pulse wave.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sympathetic nerves activity(HF)
SD method
Visual Analog Scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Turn on the LED in the booth to perform the Kraepelin test.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

Person that informed consent was provided.

Key exclusion criteria

Taking medicine affecting the autonomic system

Subjects judged by the investigator to be ineligible for other reasons

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Nomoto

Organization

University of Niigata Prefecture

Division name

University of Niigata Prefecture

Zip code

95008680

Address

471 Ebigase, Higashi-ku, Niigata

TEL

0252700122

Email

nomoto@unii.ac.jp


Public contact

Name of contact person

1st name Yohei
Middle name
Last name Nomoto

Organization

University of Niigata Prefecture

Division name

Dept. of International Studies and Regional Development

Zip code

95008680

Address

471 Ebigase, Higashi-ku, Niigata

TEL

0252700122

Homepage URL


Email

nomoto@unii.ac.jp


Sponsor or person

Institute

University of Niigata Prefecture

Institute

Department

Personal name



Funding Source

Organization

University of Niigata Prefecture

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Suzuka University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Niigata Prefecture

Address

471 Ebigase, Higashi-ku, Niigata

Tel

0252701300

Email

unp@unii.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 09 Month 29 Day

Date of IRB

2024 Year 08 Month 29 Day

Anticipated trial start date

2024 Year 09 Month 29 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 08 Month 30 Day

Last modified on

2025 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063282